ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 124 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9 | -10.0% | 4,470 | 0.0% | 0.00% | – |
| Q2 2023 | $10 | -41.2% | 4,470 | -22.3% | 0.00% | -100.0% |
| Q1 2023 | $17 | -32.0% | 5,754 | -46.2% | 0.00% | 0.0% |
| Q4 2022 | $25 | -99.9% | 10,699 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $20,000 | -31.0% | 10,699 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $29,000 | -14.7% | 10,699 | -6.4% | 0.00% | -50.0% |
| Q1 2022 | $34,000 | -37.0% | 11,431 | -18.2% | 0.00% | 0.0% |
| Q4 2021 | $54,000 | +17.4% | 13,982 | +0.6% | 0.00% | 0.0% |
| Q1 2021 | $46,000 | -20.7% | 13,900 | -15.2% | 0.00% | -33.3% |
| Q4 2020 | $58,000 | – | 16,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 260,000 | $866,000 | 0.34% |
| RTW INVESTMENTS, LP | 5,978,355 | $19,908,000 | 0.31% |
| GSA CAPITAL PARTNERS LLP | 309,839 | $1,032,000 | 0.17% |
| QCM Cayman, Ltd. | 12,728 | $42,000 | 0.13% |
| COWEN AND COMPANY, LLC | 486,717 | $1,621,000 | 0.11% |
| Hudson Bay Capital Management LP | 1,400,000 | $4,662,000 | 0.06% |
| Kerrisdale Advisers, LLC | 208,150 | $693,000 | 0.05% |
| Secure Asset Management, LLC | 10,000 | $33,000 | 0.02% |
| PDT Partners, LLC | 72,500 | $241,000 | 0.02% |
| Point72 Asset Management, L.P. | 1,037,700 | $3,456,000 | 0.02% |